Related Experiment Video
Updated: Jan 28, 2026

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
Published on: March 24, 2022
BRAF Inhibition: Bridge or Boost to T-cell Therapy?
Stephanie L Goff1, Steven A Rosenberg2
1Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. stephanie.goff@nih.gov.
None:
The concept of treatment-refractory disease has evolved as checkpoint modulation has changed the therapeutic landscape for patients with metastatic melanoma. Developing meaningful salvage strategies will involve the exploration of combination therapies and new immunotherapeutics, including adoptive transfer of tumor-infiltrating lymphocytes or other T-cell-based therapy.See related article by Atay et al., p. 2783.
More Related Videos
08:05Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap
Published on: November 3, 2017
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Related Concept Videos
Design Example: Strain Gauge Bridge or Wheatstone Bridge
Bridge rectifier
Operationally, the bridge rectifier allows current flow through two of its diodes during each...
Wheatstone Bridge
Thus, for accurate resistance measurements, a...
Feedback Inhibition
Cross-bridge Cycle
Gene Therapy